Christa Dreezen
Science Park
Amsterdam, NH, Netherlands
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Identification of racial disparities across MammaPrint and BluePrint subtypes in HR + HER2- breast cancer.
Journal: NPJ breast cancer
Published: September 09, 2025
Selection of Patients With Early-Stage Breast Cancer for Extended Endocrine Therapy: A Secondary Analysis of the IDEAL Randomized Clinical Trial.
Journal: JAMA network open
Published: November 27, 2024
Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial.
Journal: JCO precision oncology
Published: January 18, 2024
A clinical validation study of MammaPrint in hormone receptor-positive breast cancer from the Austrian Breast and Colorectal Cancer Study Group 8 (ABCSG-8) biomarker cohort.
Journal: ESMO open
Published: September 04, 2020
Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis.
Journal: International journal of cancer
Published: November 23, 2019
Performance Characteristics of the BluePrint® Breast Cancer Diagnostic Test.
Journal: Translational oncology
Published: October 08, 2019
MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology.
Journal: The Journal of molecular diagnostics : JMD
Published: November 13, 2018
A breast cancer gene signature for indolent disease.
Journal: Breast cancer research and treatment
Published: March 31, 2017
Prognostic Value of MammaPrint® in Invasive Lobular Breast Cancer.
Journal: Biomarker insights
Published: August 21, 2016
Equivalence of MammaPrint array types in clinical trials and diagnostics.
Journal: Breast cancer research and treatment
Published: March 16, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026